Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2009
07/23/2009WO2009091912A2 Improved mammalian expression vectors and uses thereof
07/23/2009WO2009090787A1 Method for producing bioactive peptide or protein and recombinant animal cell
07/23/2009WO2009014782A3 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
07/23/2009WO2008041863A8 Novel genes and polypeptides associated with insecticidal activity
07/23/2009WO2008015662A8 A method of producing recombinant biological products
07/23/2009WO2007131182A8 System for high production of natural and personalized interferons
07/23/2009WO2007104000A8 Hybrid protein that converts arachidonic acid into prostacyclin
07/23/2009WO2007090294A8 Anti-bfa4 monoclonal antibodies and for cancer diagnostics and treatment
07/23/2009WO2007084922A8 Compositions and methods for humanization and optimization of n-glycans in plants
07/23/2009WO2005056752A9 Methods and compositions for delivering polynucleotides
07/23/2009US20090188000 Gene family (lbfl313) associated with pancreatic cancer
07/23/2009US20090187999 Process for Producing Exogenous Protein in the Milk of Transgenic Mammals and a Process For Purifying Proteins Therefrom
07/23/2009US20090187004 Chimeric protein comprising contains human immunodeficiency virus protein transduction domain ; protein transduction domain (PTD) having HIV Tat PTD activity, polypeptidyl fragment that contains a J-domain and a target protein
07/23/2009US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs
07/23/2009US20090186824 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
07/23/2009US20090186822 Thrombopoietic Compounds
07/23/2009US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments
07/23/2009US20090186816 Polypeptide targeting to mitochondria
07/23/2009US20090186812 Apo-2 ligand
07/23/2009US20090186409 Compositions and methods for the diagnosis and treatment of tumor
07/23/2009US20090186382 Preparation of Romidepsin
07/23/2009US20090186381 Cellulase variants with reduced inhibition by glucose
07/23/2009US20090186380 Method of secretory expression of lysostaphin in escherichia coli at high level
07/23/2009US20090186379 ERK ligands and polynucleotides encoding ERK ligands
07/23/2009US20090186378 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration
07/23/2009US20090186377 Modifications of cst-ii for increased protein expression
07/23/2009US20090186364 Method of Constructing Recombinant Proteoliposome for Diagnostic Use
07/23/2009US20090186363 Compositions and methods for the diagnosis and treatment of tumor
07/23/2009US20090186358 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof
07/23/2009US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses
07/23/2009US20090186337 N protein of a virus of the paramyxoviridae family-protein of interest fusion proteins
07/23/2009US20090186046 Hepatitis C Virus Non Structural Fusion Protein
07/23/2009US20090186033 Anti-amyloid immunogenic compositions, methods and uses
07/23/2009US20090186027 Single chain antibodies against beta-amyloid peptide
07/23/2009US20090186020 Melanocortin Receptor Binding Mimetibodies, Compositions, Methods and Uses
07/23/2009US20090186018 Compositions and methods for the treatment of rheumatoid arthritis
07/23/2009US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
07/23/2009US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof
07/23/2009CA2712112A1 Cell culture system for pancreatic islands
07/23/2009CA2711590A1 Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
07/22/2009EP2080809A1 Production of modified glycoproteins having multiple antennary structures
07/22/2009EP2080803A1 Plastid transformation vectors for expressing proinsulin fused to the cholera toxin B-subunit in plants
07/22/2009EP2080802A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
07/22/2009EP2080771A2 New interferon beta-like molecules
07/22/2009EP2080525A1 Remodeling and Glycoconjugation of Peptides
07/22/2009EP2079847A1 Peptides containing tryptophan
07/22/2009EP1802322A4 Prion protein binding materials and methods of use
07/22/2009EP1471937B1 A continuous cell line for the production of vaccines
07/22/2009EP1395669B1 Matrix attachment regions and methods for use thereof
07/22/2009EP1292697B1 Method for preparing a physiologically active il-18 polypeptide
07/22/2009EP1280900B1 Dendritic cell co-stimulatory molecules
07/22/2009EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases
07/22/2009CN101490271A Methods and materials for making simvastatin and related compounds
07/22/2009CN101490270A Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
07/22/2009CN101487038A Preparation and use of maize yellow powder protein hydrolysate with hypotensive function
07/22/2009CN101487037A Method for purifying recombinant fibroin by two-step salting-out
07/22/2009CN101486759A Human Toll-like receptor protein, related reagent and method
07/22/2009CN100516222C Variable region of monoclonal antibody against HBV S-surface antigene and gene encoding same
07/22/2009CN100516221C Nucleotide sequences of mutant swine fever viral strin, polypeptides encoded by these squences and use thereof
07/22/2009CN100516220C Serine proteinase inhibitor of bifidobacteria
07/22/2009CN100516216C Method for preparing recombinant human apolipoprotein Pro-ApoAIm
07/22/2009CN100516210C Antibody for detecting mycoplasma pheumoniae
07/22/2009CN100516194C Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
07/22/2009CN100516087C Recombinant target fusion protein GnRH-TNFam and its antitumor use
07/21/2009US7563883 Recombinant P. falciparum merozoite protein-142 vaccine
07/21/2009US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy
07/21/2009US7563881 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus
07/21/2009US7563879 receptor-based gene expression modulation system for drug screening; genetic engineering
07/21/2009US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases
07/21/2009US7563875 Useful in assays for detecting human exposure to BoNT/A and BoNT/B; continuous myeloma cell line; kits
07/21/2009US7563874 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
07/21/2009US7563873 Immunodiagnostic test kits for simple, accurate and efficient diagnosis of hepatitis B virus (HBV) infection
07/21/2009US7563869 Programmed Death 1(PD-1); bispecific antibodies comprising antibodies against human T cell receptor complex or human B cell receptor complex; autoimmune diseases
07/21/2009US7563867 PRO4356 polypeptides
07/21/2009US7563781 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis
07/21/2009US7563777 Method to induce neovascular formation and tissue regeneration
07/21/2009US7563767 Functional genomics, bioinformatics
07/21/2009US7563760 P-selectin ligand protein
07/21/2009US7563611 Transgenic bacillus mutant for use as bioreactor to express heterologous polypeptides
07/21/2009US7563609 Mutant 2,5-diketo-L-gluconic acid reductases
07/21/2009US7563599 Reshaped human antibody to human medulloblastoma cells
07/21/2009US7563598 Two or three markers (preferably N-terminal and C-terminal epitopes) are introduced into the nascent protein and the resulting wild-type and mutant proteins are detected by mass spectrometry; facilitate detection and analysis of nascent proteins translated within cellular or cell-free translation system
07/21/2009US7563597 Selecting a DNA sequence to be packaged and a papillomaviral capsid sequence, the DNA sequence to be packaged is between 7 Kb-8.5 Kb, co-transfecting the products obtained into transfectable cells, wherein the DNA sequence is packaged, and then purifying packaged particles
07/21/2009US7563596 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes
07/21/2009US7563595 Comprises nucleotide coding nicotinic receptor for use in identifying modulators for treatment of enzymatic, affective, neurodegenerative and immunological diseases
07/21/2009US7563594 Using primers applicable to multiplex PCR that simultaneously allows for the rapid and convenient determination of the presence of Campylobacter CDT and identification of species, and they can also be used in PCR-RFLP (restriction fragment length polymorphism) based typing
07/21/2009US7563589 Including EED, EZH2 and SUZ12 wherein the reconstituted complex has histone methyltransferase (HMTase) activity for lysine 27 of histone H3 (H3-K27); cancer
07/21/2009US7563583 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells
07/21/2009US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin
07/21/2009US7563450 UL16 binding protein 4
07/21/2009US7563442 Antibodies to CD40 and methods of treating cancer and enhancing immune responses
07/21/2009US7563440 vaccination against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology
07/21/2009US7563439 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue; radioimmunotherapy
07/21/2009CA2329144C New peptide fragments for protein purification
07/21/2009CA2328528C Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
07/21/2009CA2104643C Serum free medium
07/16/2009WO2009088713A1 Substantially animal protein-free recombinant furin and methods for producing same
07/16/2009WO2009088482A1 Aminotransferase and oxidoreductase nucleic acids and polypeptides and methods of using
07/16/2009WO2009088105A1 HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF
07/16/2009WO2009088065A1 HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY